1. Baricitinib 2 mg for the treatment of atopic dermatitis in North America: Long‐term efficacy and patient‐reported outcomes. Issue 12 (4th November 2022) Authors: Simpson, Eric; Armstrong, April; Boguniewicz, Mark; Chiesa Fuxench, Zelma C.; Feely, Meghan; Pierce, Evangeline; Sun, Luna; Chen, Yun‐Fei; Angle, Robinette; Silverberg, Jonathan I. Journal: Dermatologic therapy Issue: Volume 35:Issue 12(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗